Warning letter
Mylan Laboratories Limited – Unit 7: warning letter of Aug 20, 2020
FDA warning letter 607508 · Office of Manufacturing Quality
Key facts
| Reference number | 607508 |
|---|---|
| Company | Mylan Laboratories Limited – Unit 7 |
| Subject | CGMP/API/Adulterated |
| Issue date | Aug 20, 2020 |
| Posted date | Sep 1, 2020 |
| Issuing office | Office of Manufacturing Quality |
| Product type | Drugs |
| Inspection city | Medak District, Hyderabad |
| Inspection start date | Feb 24, 2020 |
| Letter on fda.gov | fda.gov |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: